Alnylam Pharmaceuticals, Inc.

Rockefeller Capital Management L.P. ALNY

Report date

12/31/2025

Quarter

2025 Q4

Filed

3/16/2026

Shares

8,124

Value ($000)

3,231

Weight

0.0%

2019 Q4 - 2025 Q4 (19 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	3/16/2026	3,231	0.0%	8,124	12/31/2025
2025 Q3	11/14/2025	1,998	0.0%	4,380	9/30/2025
2024 Q1	5/14/2024	1,601	0.0%	10,715	3/31/2024
2023 Q4	2/14/2024	2,119	0.0%	11,073	12/31/2023
2023 Q3	11/14/2023	2,335	0.0%	13,184	9/30/2023
2023 Q1	5/16/2023	1,668	0.0%	8,339	3/31/2023
2022 Q4	3/6/2023	2,534	0.0%	10,671	12/31/2022
2022 Q3	11/2/2022	2,337	0.0%	11,681	9/30/2022
2022 Q2	8/12/2022	2,586	0.0%	17,748	6/30/2022
2022 Q1	5/13/2022	61,062	0.3%	373,964	3/31/2022
2021 Q4	2/14/2022	65,500	0.3%	386,260	12/31/2021
2021 Q3	11/12/2021	60,058	0.3%	318,100	9/30/2021
2021 Q2	8/10/2021	67,350	0.4%	397,309	6/30/2021
2021 Q1	5/11/2021	56,553	0.4%	400,560	3/31/2021
2020 Q4	2/12/2021	50,523	0.4%	388,745	12/31/2020
2020 Q3	11/13/2020	56,024	0.5%	384,796	9/30/2020
2020 Q2	8/12/2020	57,096	0.6%	385,495	6/30/2020
2020 Q1	5/12/2020	39,410	0.5%	362,055	3/31/2020
2019 Q4	2/7/2020	60,252	0.8%	523,149	12/31/2019